Cargando…

Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: A Review

Gamma-hydroxybutyric acid (GHB) is a short-chain fatty acid structurally similar to the inhibitory neurotransmitter γ-aminobutyric acid. Clinical trials have demonstrated that 50–100 mg/kg of GHB fractioned into three or six daily doses is able to suppress alcohol withdrawal symptoms and facilitates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caputo, Fabio, Vignoli, Teo, Maremmani, Icro, Bernardi, Mauro, Zoli, Giorgio
Formato:	Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705225/ https://www.ncbi.nlm.nih.gov/pubmed/19578468 http://dx.doi.org/10.3390/ijerph6061917

Ejemplares similares

Long-Term γ-Hydroxybutyric Acid (GHB) and Disulfiram Combination Therapy in GHB Treatment-Resistant Chronic Alcoholics
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Gamma-Hydroxybutyrate (GHB) With-Drawal
por: Everett, Worth
Publicado: (2001)

Current Insights on the Impact of Gamma-Hydroxybutyrate (GHB) Abuse
por: Tay, Emma, et al.
Publicado: (2022)

Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study
por: Kamal, Rama M, et al.
Publicado: (2015)

Symptoms and signs in interpreting Gamma-hydroxybutyrate (GHB) intoxication - an explorative study
por: Stomberg, Margareta Warrén, et al.
Publicado: (2014)

A Critical Evaluation of the Gamma‐Hydroxybutyrate (GHB) Model of Absence Seizures
por: Venzi, Marcello, et al.
Publicado: (2014)

A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder
por: Caputo, Fabio, et al.
Publicado: (2016)

γ-Hydroxybutyric Acid (GHB) Is Not an Agonist of Extrasynaptic GABA(A) Receptors
por: Connelly, William M., et al.
Publicado: (2013)

Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial
por: Beurmanjer, Harmen, et al.
Publicado: (2018)

Easy and convenient millimole‐scale synthesis of new, potential biomarkers for gamma‐hydroxybutyric acid (GHB) intake: Feasible for analytical laboratories
por: Steuer, Christian, et al.
Publicado: (2022)

A Retrospective Metabolomics Analysis of Gamma-Hydroxybutyrate in Humans: New Potential Markers and Changes in Metabolism Related to GHB Consumption
por: Wang, Tingting, et al.
Publicado: (2022)

Symptoms of Protracted Alcohol Withdrawal in Patients with Alcohol Use Disorder: A Comprehensive Systematic Review
por: Gallus, Silvano, et al.
Publicado: (2023)

Targeted screening of succinic semialdehyde dehydrogenase deficiency (SSADHD) employing an enzymatic assay for γ-hydroxybutyric acid (GHB) in biofluids
por: Wernli, C., et al.
Publicado: (2016)

Effect of Repeated Administration of ɣ-Valerolactone (GVL) and GHB in the Mouse: Neuroadaptive Changes of the GHB and GABAergic System
por: Frisoni, Paolo, et al.
Publicado: (2023)

Prise en charge de l’intoxication au γ-hydroxybutyrate (GHB) et son sevrage
por: Weaver, Victoria K., et al.
Publicado: (2023)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

GHB acid: A rage or reprive
por: Kapoor, Prakhar, et al.
Publicado: (2013)

Inpatient treatment of GHB/GBL dependence: a case report
por: Delic, M.
Publicado: (2023)

Understandings, attitudes, practices and responses to GHB overdose among GHB consumers
por: Freestone, Jack, et al.
Publicado: (2023)

Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The Netherlands
por: Beurmanjer, Harmen, et al.
Publicado: (2020)

Urinary concentrations of GHB and its novel amino acid and carnitine conjugates following controlled GHB administration to humans
por: Steuer, Andrea E., et al.
Publicado: (2023)

GHB: a life-threatening drug complications and outcome of GHB detoxification treatment—an observational clinical study
por: Neu, Peter, et al.
Publicado: (2023)

Six-Month Outcome in Bipolar Spectrum Alcoholics Treated with Acamprosate after Detoxification: A Retrospective Study
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2014)

Effect of GHB-use and GHB-induced comas on dorsolateral prefrontal cortex functioning in humans
por: Raposo Pereira, Filipa, et al.
Publicado: (2018)

Effects of Recreational GHB Use and Multiple GHB-Induced Comas on Brain Structure and Impulsivity
por: Raposo Pereira, Filipa, et al.
Publicado: (2020)

Chronic gamma-hydroxybutyric-acid use followed by gamma-hydroxybutyric-acid withdrawal mimic schizophrenia: a case report
por: Constantinides, Prometheas, et al.
Publicado: (2009)

Harm Reduction as “Continuum Care” in Alcohol Abuse Disorder
por: Maremmani, Icro, et al.
Publicado: (2015)

Characterization of the GHB Withdrawal Syndrome
por: Wolf, Casper J. H., et al.
Publicado: (2021)

Smartphone‐based colorimetric determination of gamma‐butyrolactone and gamma‐hydroxybutyrate in alcoholic beverage samples
por: Procida, Anselmo, et al.
Publicado: (2022)

Successful Treatment of Severe Gamma-Hydroxybutyric Acid Withdrawal Syndrome With Dantrolene
por: Röell, Anna Eveline, et al.
Publicado: (2021)

Acute Gamma Hydroxybutyrate Toxicity
por: Schneir, Aaron B.
Publicado: (2001)

Urinary Profile of Endogenous Gamma-Hydroxybutyric Acid and its Biomarker Metabolites in Healthy Korean Females: Determination of Age-Dependent and Intra-Individual Variability and Identification of Metabolites Correlated With Gamma-Hydroxybutyric Acid
por: Kim, Suji, et al.
Publicado: (2022)

A pharmacokinetic evaluation and metabolite identification of the GHB receptor antagonist NCS‐382 in mouse informs novel therapeutic strategies for the treatment of GHB intoxication
por: Ainslie, Garrett R., et al.
Publicado: (2016)

Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Determination of Endogenous GHB and GHB-Glucuronide in Nails
por: Busardò, Francesco Paolo, et al.
Publicado: (2018)

What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients
por: Maremmani, Angelo G.I., et al.
Publicado: (2019)

Has GBL Replaced GHB in Recreational Settings?
por: Tini, Anastasio, et al.
Publicado: (2020)

Can Ropinirole Modulate Reinforcing Subjective Effects of Cocaine in Humans?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry
por: Maremmani, Icro, et al.
Publicado: (2012)

GABA(B) receptor-mediated activation of astrocytes by gamma-hydroxybutyric acid
por: Gould, Timothy, et al.
Publicado: (2014)

Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture?
por: Spera, Vincenza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rl3kcmn8jlh1nn2vrkhke8v2e7